These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11834592)

  • 41. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkinson's disease: genetics and pathogenesis.
    Shulman JM; De Jager PL; Feany MB
    Annu Rev Pathol; 2011; 6():193-222. PubMed ID: 21034221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
    Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
    Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A linkage study of candidate loci in familial Parkinson's Disease.
    Wirdefeldt K; Burgess CE; Westerberg L; Payami H; Schalling M
    BMC Neurol; 2003 Jul; 3():6. PubMed ID: 12882651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
    Halliday G; McCann H; Shepherd C
    Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective study of 50 cases of familial Parkinson's disease.
    Roy M; Boyer L; Barbeau A
    Can J Neurol Sci; 1983 Feb; 10(1):37-42. PubMed ID: 6839226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?
    Inzelberg R; Polyniki A
    J Neurol Sci; 2010 Feb; 289(1-2):23-6. PubMed ID: 19740488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.
    Wider C; Skipper L; Solida A; Brown L; Farrer M; Dickson D; Wszolek ZK; Vingerhoets FJ
    Parkinsonism Relat Disord; 2008 Aug; 14(6):465-70. PubMed ID: 18342564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical and genetic study of familial cases of Parkinson's disease.
    Planté-Bordeneuve V; Taussig D; Thomas F; Ziégler M; Said G
    J Neurol Sci; 1995 Nov; 133(1-2):164-72. PubMed ID: 8583221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.
    Kempster PA; O'Sullivan SS; Holton JL; Revesz T; Lees AJ
    Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical and pathological characterization of Lrrk2.
    Giasson BI; Covy JP; Bonini NM; Hurtig HI; Farrer MJ; Trojanowski JQ; Van Deerlin VM
    Ann Neurol; 2006 Feb; 59(2):315-22. PubMed ID: 16437584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autosomal dominant Lewy-body Parkinson's disease.
    Golbe LI; Miller DC; Duvoisin RC
    Adv Neurol; 1990; 53():287-92. PubMed ID: 2173372
    [No Abstract]   [Full Text] [Related]  

  • 59. Milestones in Parkinson's disease--clinical and pathologic features.
    Halliday G; Lees A; Stern M
    Mov Disord; 2011 May; 26(6):1015-21. PubMed ID: 21626546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurochemical and neurogenetic correlates of Parkinson's disease.
    Mizuno Y; Hattori N; Matsumine H
    J Neurochem; 1998 Sep; 71(3):893-902. PubMed ID: 9721714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.